Gastrointestinal motility and functional gastrointestinal diseases

Current Pharmaceutical Design

Volumn 20, Issue 16, 2014, Pages 2775-2782

  Kusano, Motoyasu ^a   Hosaka, Hiroko ^a   Kawada, Akiyo ^a   Kuribayashi, Shiko ^a   Shimoyama, Yasuyuki ^a   Zai, Hiroaki ^a   Kawamura, Osamu ^a   Yamada, Masanobu ^a  

^a GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Functional dyspepsia (FiD); Gastroesophageal reflux disease (GERD); Interdigestive migrating contractions (IMC); Prokinetics; Rome III

Indexed keywords

CASEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMATE SODIUM; OPIATE AGONIST; PROKINETIC AGENT; SEROTONIN AGONIST;

ANOREXIA; ARTICLE; ASCENDING COLON; AUTONOMIC NERVOUS SYSTEM; DESCENDING COLON; DUODENUM; DYSPEPSIA; ESOPHAGUS MOTILITY; FUNCTIONAL DISEASE; FUNCTIONAL GASTROINTESTINAL DISEASE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INTERDIGESTIVE MIGRATING CONTRACTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HERBAL MEDICINE; HOSPITAL SERVICE; HUMAN; INTERDIGESTIVE MIGRATING CONTRACTION; INTESTINE; INTESTINE MOTILITY; JAPAN; NONCARDIAC CHEST PAIN; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RECTUM; SIGMOID; STOMACH EMPTYING; STOMACH MUSCLE; TRANSVERSE COLON; ANIMAL; DRUG EFFECTS; GASTROINTESTINAL DISEASES; PHYSIOLOGY;

ANIMALS; GASTRIC EMPTYING; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; POSTPRANDIAL PERIOD; SODIUM GLUTAMATE;

EID: 84903728958     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990572     Document Type: Article

References (127)

1. Goyal RK, Paterson WG. Esophageal motility. In: Handbook of Physiology. The Gastrointestinal System. Motility and Circulation. Bethesda, MD: Am Physiol Soc., 1989, sect. 6, vol I, pt.2, chapt. 22, pp.865-908.
2. Hirsch DP, Holloway RH, Tytgat GNJ, et al. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 1998; 115: 1374-80.
3. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307: 1547-52.
4. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995; 109: 601-10.
5. Dodds WJ, Hogan WJ, Helm JF, et al. Pathogenesis of reflux esophagitis. Gastroenterology 1981; 81: 376-94.
6. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006; 131: 640-58.
7. Itoh Z, Takahashi I. Periodic contractions of the canine gallbladder during the interdigestive state. Am J Physiol 1981; 240: G183-9.
8. Suzuki H, Mochiki E, Haga N, et al. Motilin controls cyclic release of insulin through vagal cholinergic muscarinic pathways in fasted dogs. Am J Physiol 1998; 274: G87-95.
9. Mochiki E, Inui A, Satoh M, et al. Motilin is a biosignal controlling the cyclic release of pancreatic polypeptide via the vagus in fasted dogs. Am J Physiol 1997; 272: G1-G9.
10. Itoh Z. Effect of motilin on gastrointestinal motor activity in the dog. In Motilin. Z Itoh (ed). San Diego, Academic Press, 1990, pp133-54.
11. Kusano M, Sekiguchi T, Nishioka T, et al. The relationship between interdigestive gallbladder and gastroduodenal motility in man. Gastroenterologia Jap 1990; 25: 568-74.
12. Tack J, Depoortere, I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-33.
13. Nakajima H, Mochiki E, Zietlow A, et al. Mechanism of interdigestive migrating motor complex in conscious dogs. J Gastroenterol 2010; 45: 506-14.
14. Zietlow A, Nakajima H, Taniguchi H, et al. Association between plasma ghrelin and motilin levels during MMC cycle in conscious dogs. RegulPept 2010; 164: 78-82.
15. Ogawa A, Mochiki E, Yanai M, et al. Interdigestive migrating contractions are coregulated by ghrelin and motilin in conscious dogs. Am J Physiol 2012; 302: R233-41.
16. Fujimiya M, Okumiya K, Kuwahara A. Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure. Hist Cell Biol 1997; 108: 105-13.
17. Fandrinks L, Mattsson A, Dalenback J, et al. Gastric output of IgA in man: relation to migrating motility complexes and sham feeding. Scand J Gastroenterol 1995; 30: 657-63.
18. Vantrappen G, JanssensJ, Hellemans J, et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59: 1158-66
19. Testoni PA, Bagnolo F, Masci E, et al. Different interdigestive antroduodenal motility patterns in chronic antral gastritis with and without Helicobacter pylori infection. Dig Dis Sci 1993; 38: 2255-61.
20. Nieuwenhuijs VB, Verheem A, van Duijvenbode-Beumer H, et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 1998; 228: 188-93.
21. Pardo A, Bartoli R, Lorenzo-Zuniga V, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858-63.
22. Sola R, Soriano G. Why do bacterial reach ascitic fluid? Eur Gastroenterol Hepatol 2002; 14: 351-4.
23. Van Felius ID, Akkermans LM, Bosscha K, et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 2003; 15: 267-276.2003
24. Porras M, Martin MT, Soler M, et al. Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis. Am J Physiol 2004; 287: G58-G64.
25. Kusano M, Sekiguchi T, Kawamura O, et al. Disturbed initiation of gastric interdigestive migrating complexes despite high plasma motilin levels in patients with low gastric pH. Dig Dis Scie 1998; 43: 1697-700.
26. Kusano M Sekiguchi T, Kawamura O, et al. Further classification of dysmotility-like dyspepsia by interdigestive gastroduodenal manometry and plasma motilin level. Am J Gastroenterol 1997; 92: 481-4.
27. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92: 1885-93.
28. Tremolaterra F, Villoria A, Azpiroz F, et al. Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating. Gastroenterology 2006; 130: 1062-8.
29. Hernando-Harder AC, Riddinger F, Krammer HJ, et al. Impaired intestinal gas clearance during marked hyperglycemia in patients with functional abdominal bloating. Digestion 2006; 74: 155-61
30. Accarino A, Perez F, Quiroga S, et al. Abdominal distention results from caudo-ventral redistribution of contents. Gastroenterology 2009; 136: 1544-51.
31. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292: 852-8.
32. Agrawal A, Houghton LA, Reilly B, et al. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit. Am J Gastroenterol 2009; 104: 1998-2004.
33. Pimentel M, Chow EJ, Lin HC. Eradication small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-6.
34. De Schepper HV, Cremonini F, Chittcara D, et al. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol. Motil. 2004; 16: 275-85.
35. Feinle-Bisset C, Vazzo R, Horowitz M, et al. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-81.
36. Raybould HE. Visceral perception: sensory transduction in visceral afferents and nutrients. Gut 2002; 51 Suppl 1: i1-i4.
37. Nakamura K, Takahashi T, Taniuchi M, et al. Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus. J Clin Invest 1998; 101: 1479-89.
38. Janssen P, Tack, Sifrim D, et al. Influence of 5-HT1 receptor agonists on feline stomach relaxation. Eur J Pharmacol 2004; 492: 259-67.
39. Zai H, Kusano M, Hosaka H, et al. Monosodium L-glutamate added to a high-energy, high-protein liquid diet promotes gastric emptying. Am J Clin Nutr 2009; 89: 431-5.
40. Feinle-Bisset C, Vazzo R, Horowitz M, et al. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-81.
41. Kusano M, Minashi K, Maeda M, et al. Postprandial water intake inhibits gastric antral motility with increase of cholecystokinin in humans. Scand J Gastroenterol 2005; 40: 1176-81.
42. Shimoyama Y, Kusano M, Kawamura O, et al. High-viscosity liquid meal accelerates gastric emptying. Neurogastroenterol Motil 2007; 19: 879-86
43. Zai H, Kusano M. Investigation of gastric emptying disorders in patients with functional dyspepsia reveals impaired inhibitory gastric emptying regulation in the early postcibal period. Digestion 2009; 79(suppl) 1; 13-8.
44. Stanghelini V, Malagelada JR, Zinsmeister AR, et al. Stressinduced gastroduodenal motor disturbances in man: Possible humoral mechanisms. Gastroenterology 1983; 85: 83-91.
45. Gue M, Junien JL, Bueno L. The kappa agonist fedotozine modulates colonic distension induduced inhibition of gastric motility and emptying in dogs. Gastroenterology 1994; 107: 1327-34.
46. Tjeerdsma HC, Smout AJ, Akkermans LM. Voluntary suppression of defecation delays gastric emptying. Dig Dis Scie 1993; 38: 832-6.
47. Teff KL, Alavi A, Chen J, et al. Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender. Am J Physiol. 1992; 276: G707-14.
48. Krevsky B, Malmud LS, D'Ercole F, et al. Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans. Gastroenterology 1986; 91: 1102-12.
49. Wood JD. Neurogasterology and digestive motility. In: Rhoades RA and Tanner GA,(eds). Medical Physiology. 2nd ed. Baltimore: Lippincott Williams and Wilkins, 2003; pp449-80.
50. Sarna SK. Giant migrating contractions and their myoelectric correlates in the small intestine. Am J Physiol 1987; 253: G697-05.
51. Rao SS, Sadeghi P, Beaty J, et al. Ambulatory 24-h colonic manometry in healthy humans. Am J Physiol 2001; 280: G629-39.
52. Sun WM, Read NW. Anorectal function in normal human subjects: effect of gender. Int J Colorectal Dis 1989; 4: 188-96.
53. Wood JD. Integrative functions of the enteric nervous system. In: Johnson LR et al., (eds). Physiology of the Gastrointestinal Tract 4thed. San Diego, Elsevier, 2006.
54. Kamm MA, van der Sijp JR, Lennard-Jones JE. Colorectal and anal motility during defecation. Lancet 1992; 339: 820.
55. rd, et al. Differential chemosensory function and receptor expression of splanchnic and pelvic afferents in mice. J Physiol 2005; 567: 267-81.
56. Bassotti G, Crowell MD, Whitehead WE. Contractile activity of the human colon: lessons from 24 hour studies. Gut 1993; 34: 129-33.
57. Yamanouchi M, Shimatani H, Kadowaki M, et al. Integrative control of rectoanal reflex in guinea pigs through lumbar colonic nerves. Am J Physiol 2002; G148-56.
58. Sun WM, Read NW, Miner PB. Relation between rectal sensation and anal function in normal subjects and patients with faecal incontinence. Gut 1990; 31: 1056-61.
59. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006; 131: 1925-42.
60. Rattan S, Mounni C, Chakder S. CGRP and ANF cause relaxation of opossum internal anal sphincter via different mechanisms. Am J Physiol 1991; 206: G764-9.
61. Rattan S, Chakder S. Role of nitric oxide as amediator of internal anal sphincter relaxation. Am J Physiol 1992; 262: G107-12.
62. Rathi S, Kazerounian S, Banwait K, et al. Functional and molecular characterization of β-adrenoceptors in the internal anal sphincter. J PharmacolExpTher 2003; 305: 615-24.
63. Patel CA, Rattan S. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK as compared with the phasic smooth muscle. Am J Physiol 2006; 291: G830-7.
64. Rattan S, Godoy MA, Patel CA. Rho kinase as novel molecular therapeutic target for hypertensive internal anal sphincter. Gastroenterology 2006; 131: 108-16.
65. Yamanouchi M, Shimatani H, Kadowaki M, et al. Integrative control of rectoanal reflex in guinea pigs through lumbar colonic nerve. Am J Physiol 2002; 289: G148-56.
66. Pandolfino JE, Fox MR, Bredenoord AJ, et al. High-resolution manometry in clinical practice: utilizing pressure topography to classifiy oesophageal motility abnormalities. Neurogastroenterol Motil 2009; 21: 796-806.
67. Clouse RE. Spastic disorders of the esophagus. Gastroenterology 1997; 5: 112-27.
68. Richter JE, Dalton CB, Bradley LA, et al. Oral nifedipine in the treatment of non-cardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 1987; 93: 21-8
69. Balaban DH, Yamamoto Y, Liu J, et al. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology 1999; 116: 29-37
70. Boesmans W, Berghe PV, Farre R, et al. Oesophageal shortening: in vivo validation of high-frequency ultrasound measurements of oesophageal muscle wall thickness. Gut 2010; 59: 433-40.
71. Vakil N, vanZanten SV, Kahrilas P, et al. Global consensus group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
72. Modlin IM, Hunt RH, Malfertheiner P, et al. Diagnosis and management of non-erosive reflux disease-The Vevey NERD consensus group. Digestion 2009; 80: 74-88.
73. Roman S, Zerbid F, Belhocine K, et al. High resolution manometry to detect transient lower oesophageal sphincter relaxations: diagnostic accuracy compared with perfused-sleeve manometry, and the definition of new criteria. Aliment PharmacolTher 2011; 34: 384-93.
74. Kawamura O, Sekiguchi T, Kusano M, et al. Endoscopic ultrasonographic abnormalities and lower esophageal sphincter function in reflux esophagitis. Dig Dis Scie 1995; 40: 598-605.
75. Leite LP, Johnston BT, Barrett J, et al. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Scie 1997; 42: 1859-65.
76. Betraccini G, Coruzzi G. Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine. Agents and Actions 1982; 12: 168-71.
77. Robinson M, Horn J. Clinical pharmacology of proton pump inhibitors: what the practicing physician needs to know. Drugs. 2003; 63: 2739-54.
78. Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992; 51 Suppl 1: 59-67.
79. Zhang Q, Lehmann A, Rigda R, et al. Control of transient lower oesophageal sphincter relaxation and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 50: 19-24.
80. Lehmann A, Antonsson M, Holmberg AA, et al. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action. J PharmacolExpTher. 2009; 331: 504-12.
81. Kuo P, Holloway RH. Beyond acid suppression: new pharmacologic approaches for treatment of GERD. Curr Gastroenterol Rep. 2010; 12: 175-80
82. Frisby CL, Mattson JP, Jensen JM, et al. Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands. Gastroenterology 2005; 129: 995-1004
83. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45 (Suppl 2): 1137-42.
84. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-79.
85. Bisschops R, Karamanolis G, Arts J, et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 2008; 57: 1495-503
86. Malagelada JR, Stanghelline V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 1223-31
87. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-42.
88. Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-52.
89. Tack J, Caenepeel P, Geypens B, et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-35.
90. Talley NJ, Locke GR III, Lahr B, et al. Functional dyspepsia, delayed gastric emptying and impaired quality of life. Gut 2006; 23: 923-36.
91. Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783-8.
92. Cuomo R, Sarnelli G, Grasso R, et al. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships. Scand J Gastroenterol 2001; 36: 1030-6.
93. Kolbel CB, Layer P, Holtman G, et al. The effect of a new synthetic cholinergic compound (aclatonuumnapadisilate) on interdigestive motility and pancreatic function in humans. Int J Pancreatol 1998; 5: 273-9.
94. Perkel MS, Moore C, Hersh T, et al. Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study. Dig Dis Scie 1979; 24: 662-6.
95. Arienti V, Corazza GR, Sorge M, et al. The effects of levosulpiride on gastric and gallbladder emptying in functional dyspepsia. Aliment PharmacolTher 1994; 8: 631-8.
96. Brogden RN, Carmine AA, Heel RC, et al. Domperidone: a review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24: 360-400.
97. Holtmann G, Talley NJ, Liebregts T, et al. A placebo-control trial of itopride in fuctional dyspepsia. N Engl J Med 2006; 354: 832-40.
98. Tally NJ. Serotoninergic neuroenteric modulators. Lancet 2001; 385: 2061-8.
99. Hongo M, Harasawa S, Mine T, et al. A large-scale, randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS). J Gastroenterol Hepatol 2012; 27: 62-8.
100. Matsueda K, Hongo M, Tack J, at al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61: 821-8.
101. Taniyama K, Sano I, Nakayama S, et al. Dual effect of trimebutine on contractility of the guinea pig ileum via the opioid receptors. Gastroenterology 1991; 101: 1579-87
102. Kido T, Nakai Y, Kase Y, et al. Effect of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N-nitro-L-arginine. J Pharmacol Sci 2005; 98: 161-7
103. Hayakawa T, Arakawa T, Kase Y, et al. Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exptl Clin Res 1999; 25: 211-8.
104. Tominaga K, Kido T, Ochi M, et al. The traditional Japanese medicine rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT3 receptor pathway in rats. Evid Based Complement Alternat Med 2009; 1-8.
105. Takeda H, Sadakane C, Hattori T, et al. Rikkunshito, a herbal medicine, suppresses cisplatin-induced anorexia in rats by 5-HT2 receptor antagonism. Gastroenterology 2008; 134: 2004-13.
106. Yakabi K, Kurosawa S, Tamai M, et al. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induce anorexia via hypothalamic ghrelin interaction. RegulPept. 2010; 161: 97-105.
107. Fujitsuka N, Asakawa A, Hayashi M, et al. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry 2009; 65: 748-59.
108. Matsumura T, Arai M, Yonemitsu Y: The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol. 2010; 45: 300-7.
109. Vasilevskaia LS, Rymshina MV, Shlygin GK. [Effect of glutamate and combined with inosine monophosphate on gastric secretion]. VoprPitan 1993: 29-33.
110. Spielman AI. Interaction of saliva and taste. J Dent Res 1990; 69: 838-43.
111. Ohara I, Otsuka SI, Yugari Y. The influence of carrier of gustatory stimulation on the cephalic phase of canine pancreatic secretion. J Nutr 1979; 109: 2098-105.
112. Ohara I, Otsuka S, Yugari Y. Cephalic phase response of pancreatic exocrine secretion in conscious dogs. Am J Physiol 1988; 254: G424-8.
113. Raybould HE. Visceral perception: sensory transduction in visceral afferents and nutrients. Gut 2002; 51 Suppl 1: 11-4.
114. Graham TE, Sgro V, Friars D, Gibala MJ. Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans. Am J Physiol Endocrinol Metab 2000; 278: E83-89.
115. Lindemann B. A taste for umami. Nat Neurosci 2000; 3: 99-100.
116. Lindemann B. Receptors and transduction in taste. Nature 2001; 413: 219-25.
117. Toyono T, Seta Y, Kataoka S, et al. Expression of the metabotropic glutamate receptor, mGluR4a, in the taste hairs of taste buds in rat gustatory papillae. Arch HistolCytol 2002; 65: 91-6.
118. Toyono T, Seta Y, Kataoka S, Kawano S, Shigemoto R, Toyoshima K. Expression of metabotropic glutamate receptor group I in rat gustatory papillae. Cell Tissue Res 2003; 313: 29-35.
119. Chaudhari N, Landin AM, Roper SD. A metabotropic glutamate receptor variant functions as a taste receptor. Nat Neurosci 2000; 3: 113-9.
120. San Gabriel A, Uneyama H, Yoshie S, Torii K. Cloning and characterization of a novel mGluR1 variant from vallate papillae that functions as a receptor for L-glutamate stimuli. Chem Senses 2005; 30 Suppl 1: i25-6.
121. Nelson G, Chandrashekar J, Hoon MA, et al. An amino-acid taste receptor. Nature 2002; 416: 199-202.
122. Zhao GQ, Zhang Y, Hoon MA, et al. The receptors for mammalian sweet and umami taste. Cell 2003; 115: 255-66.
123. Schwartz GJ, Moran TH. Duodenal nutrient exposure elicits nutrient-specific gut motility and vagal afferent signals in rat. Am J Physiol 1998; 274: R1236-42.
124. Bezencon C, le Coutre J, Damak S. Taste-signaling proteins are coexpressed in solitary intestinal epithelial cells. Chem Senses 2007; 32: 41-49.
125. San Gabriel AM, Maekawa T, Uneyama H, Yoshie S, Torii K. mGluR1 in the fundic glands of rat stomach. FEBS Lett 2007; 581: 1119-23.
126. Uneyama H, Niijima A, San Gabriel A, Torii K. Luminal amino acid sensing in the rat gastric mucosa. Am J Physiol Gastrointest Liver Physiol 2006; 291: G1163-70.
127. Hosaka H, Kusano M, Zai H, et al. Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing meal. Aliment Pharmacol Ther 2012; 36: 895-903.